Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07511361
PHASE2

Study of Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital

Sponsor: Kardigan, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently discharged from the hospital, after treatment for acute severe hypertension.

Official title: A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tonlamarsen in Participants With Acute Severe Hypertension Recently Discharged From the Hospital

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2026-04-20

Completion Date

2027-02-23

Last Updated

2026-04-06

Healthy Volunteers

No

Interventions

DRUG

Tonlamarsen

Tonlamarsen will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study

DRUG

Placebo

Placebo will be administered subcutaneously (under the skin) every 4 weeks during the randomized part of the study

Locations (1)

Progressive Medical Research

Port Orange, Florida, United States